Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2632975 | Journal of Obstetric, Gynecologic & Neonatal Nursing | 2011 | 5 Pages |
Abstract
Despite Black race having been identified as a contributor to RDS mortality in the past, race was not a predictor of RDS mortality in the 2005 cohort. Previous analyses comparing preâ and postsurfactant era mortality assumed that all eligible infants received surfactant, and Black infants did not respond as well as White infants. The 2003 birth certificate revision included surfactant administration, but only 12 states reported that data in the 2005 data set. Only 22% of eligible infants had documentation of surfactant administration. Future research is needed to confirm that eligible infants are receiving surfactant and to evaluate the response of infants by race. If Black infants do not respond to the available surfactant replacement products, genomics research is needed to explore targeted therapies for this group.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Patricia E. Thomas,